News And Announcements
N4 Pharma upbeat on latest 'nuvec' study results
Specialist pharmaceutical company N4 Pharma announced the results of its latest study for its ‘nuvec’ silica nanoparticles (SiNPs) delivery system.
OptiBiotix reveals new, improved SlimBiome platform
Life sciences business OptiBiotix Health issued a product development and commercial update on its ‘SlimBiome’ product platform on Thursday, reporting that it was launching a new improved version of the platform following the announcement of the manufacturing and supply agreement with Knighton Foods on 1 November.
Fulcrum's electricity assets unit gets crucial Ofgem licence
Multi-utility infrastructure and services provider Fulcrum Utility Services announced on Wednesday that its operating subsidiary Fulcrum Electricity Assets has been granted an independent distribution network operator (iDNO) licence by the Office of Gas and Electricity Markets - Ofgem.
Craneware starts year well, investors told
Investors in healthcare software and supporting services supplier Craneware were told on Wednesday that the company has experienced a “positive start” to trading in the first four months of the year, as they gathered for the annual general meeting.
GKN lining up China joint venture - report
Engineer GKN is close to setting up a joint venture with Chinese state aerospace manufacturer Comac, according to a report on Wednesday.
Duke Royalty enters advisory agreement with Partners Value Investments
Diversified royalty company Duke Royalty announced a new advisory agreement with Partners Value Investments on Wednesday.
Stadium Group warns on profits as transition progresses slowly
Design-led technology supplier Stadium Group updated the market on its trading in Wednesday, reporting that “significant progress” was continuing to be made in transitioning from a purely electronic assemblies business to a design-led technology business.
GlaxoSmithKline appoints Hal Barron as R&D boss, replacing Vallance
GlaxoSmithKline has appointed Hal Barron - currently president of research & development at Alphabet-funded Calico - as chief scientific officer and president of R&D, replacing Patrick Vallance.
Paul Haworth joins GetBusy as CFO
GetBusy announced on Wednesday that Paul Haworth has joined the company as chief financial officer, initially in a non-board position.
ReNeuron makes solid progress with hRPC trials
Cell-based therapeutics developer ReNeuron Group updated the market on Wednesday on its ongoing Phase I/II clinical trial of its hRPC cell therapy candidate for the blindness-causing disease retinitis pigmentosa.
Genedrive COO Allan Brown to leave
AIM-listed Genedrive has announced the departure of chief operating officer, Allan Brown, with immediate effect.
Rio Tinto eyeing £4bn stake in Chilean lithium producer - reports
Rio Tinto is said to be mulling the acquisition of a $5bn (£3. 8bn) stake in a Chilean lithium producer as demand for the metal surges due to its use in electric car batteries.
Snoozebox appoints administrators
Snoozebox has appointed administrators after discussions with its primary lender failed to bear fruit.
Ricardo orders rise on electric and hybrid vehicle projects
Ricardo has made a strong start to its financial year after an increase in orders connected with electric or hybrid vehicles.
Sky News future in doubt if Fox deal is blocked
Broadcaster Sky has said it would have to review the future of its Sky News operation if regulators were to block a proposed move for 21st Century Fox to purchase the 61% of the company it does not currently own.
Wetherspoon chairman attacks fellow bosses for Brexit 'misinformation'
JD Wetherspoon's chairman has accused bosses of other companies of spreading misinformation about the impact of Brexit as the pub chain reported higher first-quarter sales.
Bob Foster back in CEO seat at Stratex
Stratex updated the market on its search for a CEO on Wednesday, given the board has been reviewing its composition and the future direction of the company in light of the outcome of the general meeting on 1 November and the termination of the proposed acquisition of Crusader Resources.
Benchmark reveals development of disease-resistant shrimp
Aquaculture health, nutrition, breeding and genetics company Benchmark Holdings has developed specific pathogen resistant (SPR) shrimp, it announced on Wednesday, to address issues facing the Asian market - the largest and fastest growing market for shrimp.
FCA examines wholesale insurance brokers
The Financial Conduct Authority has announced an investigation into competition between wholesale insurance brokers.
Capco may give up control of housing estates in Earls Court development
Capital & Counties confirmed on Wednesday that it is in talks with the London borough of Hammersmith & Fulham about significant changes to the development of the property developer's 77-acre Earls Court development.